ACM
DERM icon

ADAR1 Capital Management’s Journey Medical DERM Stock Holding History

ADAR1 Capital Management’s Portfolio DERM Stock Details DERM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$280K Buy
+39,517
New +$226K 0.01% 237

Other funds holding DERM

WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
PAIM
Punch & Associates Investment Management Edina, Minnesota $2.02B AUM 40.6% 1-Year Est. Return
PFCS
Pale Fire Capital SE Prague, Czech Republic $1.41B AUM 25.22% 1-Year Est. Return
OM
Opaleye Management Boston, Massachusetts $1.1B AUM 197.64% 1-Year Est. Return
SF
Summit Financial Parsippany, New Jersey $9.12B AUM 27.44% 1-Year Est. Return
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return
DC
Diametric Capital Boston, Massachusetts $948M AUM 47.49% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $928M AUM 596.14% 1-Year Est. Return

ADAR1 Capital Management's DERM Position: Q2 2026 in Review

ADAR1 Capital Management opened a new position in Journey Medical (DERM) in Q2 2026: 39,517 shares worth $280K. The stake represents 0.01% of the portfolio and ranks #237 among its holdings.

71 funds tracked by Wall St. Rank hold DERM as of Q2 2026.

  • ADAR1 Capital Management held 39,517 shares of Journey Medical worth $280K as of Q2 2026.
  • Journey Medical was a new ADAR1 Capital Management position in Q2 2026.
  • Journey Medical made up 0.01% of ADAR1 Capital Management's portfolio in Q2 2026, its #237 holding.
  • 71 funds tracked by Wall St. Rank held Journey Medical as of Q2 2026.

Based on ADAR1 Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.